Profilo
Richard Lewis served as the Chief Medical Officer at Aerie Pharmaceuticals, Inc. from 2015 to 2022.
Prior to that, he received his undergraduate and doctorate degrees from Chicago Medical School.
Precedenti posizioni note di Richard Lewis
| Società | Posizione | Fine |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
Formazione di Richard Lewis
| Chicago Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Richard Lewis
